M&A Deal Summary

Elekta Acquires Resonant Medical

On May 31, 2010, Elekta acquired medical products company Resonant Medical for 30M CAD

Acquisition Highlights
  • This is Elekta’s 2nd transaction in the Medical Products sector.
  • This is Elekta’s 3rd largest (disclosed) transaction.
  • This is Elekta’s 1st transaction in Canada.
  • This is Elekta’s 1st transaction in Quebec.

M&A Deal Summary
Date 2010-05-31
Target Resonant Medical
Sector Medical Products
Buyer(s) Elekta
Deal Type Add-on Acquisition
Deal Value 30M CAD

Target

Resonant Medical

Montreal, Quebec, Canada
Resonant Medical, Inc. is a developer of revolutionary clinical solutions that are safe and gentle for the patient while increasing the accuracy and precision of radiotherapy cancer care.

Search 193,448 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Elekta

Stockholm, Sweden

website

Category Company
Founded 1972
Sector Medical Products
Employees4,614
Revenue 14.5B SEK (2022)
DESCRIPTION

Elekta is an international medical-technology Group, providing highly advanced clinical solutions for high precision radiation treatment of cancer and for non- or minimally invasive treatment of brain disorders. Clinical solutions include among others Leksell Gamma Knife® for non-invasive treatment of brain surgery and Elekta Synergy for image guided radiation therapy (IGRT) as well as associated software systems. Elekta was founded in 1972 and is based in Stockholm, Sweden.

DEAL STATS #
Overall 5 of 9
Sector (Medical Products) 2 of 2
Type (Add-on Acquisition) 5 of 9
State (Quebec) 1 of 1
Country (Canada) 1 of 2
Year (2010) 1 of 1
Size (of disclosed) 3 of 4
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2008-01-08 CMS

St. Louis, Missouri, United States

CMS, Inc. is a provider in the development and support of radiation treatment planning and workflow management solutions.

Buy $75M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-09-15 Nucletron B.V.

Veenendaal, Netherlands

Nucletron B.V. is a provider in brachytherapy treatment planning and delivery.

Buy €365M
Mergr

Product

Company

Legal